Newsroom
Announcements & milestones.
Selected laboratory news, accreditation milestones, conference activity, and facility updates.
March 18, 2026
Accreditation
VerifiedSciences renews A2LA ISO/IEC 17025:2017 accreditation with expanded cannabis scope.
Following a multi-day on-site assessment, A2LA renewed our ISO/IEC 17025 scope (Certificate 6842.01) and added pesticide residue analysis for cannabis flower and concentrates.
January 9, 2026
Instrumentation
Q Exactive Plus Orbitrap and second 7900 ICP-MS commissioned.
A second high-resolution accurate-mass platform and a redundant elemental impurities instrument complete the 2025 capital plan, doubling capacity for USP <232>/<233> and untargeted screening.
October 22, 2025
Industry
Dr. Anika Rao to present at AAPS PharmSci 360 on therapeutic peptide aggregation analysis.
Our Director of Peptide Sciences will present a peer-reviewed poster on orthogonal aggregation methods (SEC-MALS, AF4, AUC) for early-stage peptide candidates.
August 4, 2025
Facility
Microbiology suite expansion adds two BSL-2 rooms and a dedicated rapid-methods lab.
A 3,200 sq ft buildout brings the laboratory footprint to 18,400 sq ft, with separated sterility, EM, and rapid-methods workflows to eliminate cross-contamination risk.
May 12, 2025
Quality
VerifiedSciences achieves zero observations in NSF-ISR ISO 9001 surveillance audit.
Our quality management system passed surveillance with no findings or observations—our third consecutive clean audit.
February 28, 2025
Partnership
Joint development agreement with regional biotech accelerator program.
VerifiedSciences will provide subsidized analytical method development for seed-stage portfolio companies, with priority scheduling and rate protection through 2027.
Media inquiries: press@verifiedsciences.com